Preclinical efficacy of hK2 targeted [(177)Lu]hu11B6 for prostate cancer theranostics

Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated in the form of increased androgen receptor (AR) expression. Targeting proteins that are expressed as...

Descripción completa

Detalles Bibliográficos
Autores principales: Timmermand, Oskar Vilhelmsson, Elgqvist, Jörgen, Beattie, Kai A., Örbom, Anders, Larsson, Erik, Eriksson, Sophie E., Thorek, Daniel L.J., Beattie, Bradley J., Tran, Thuy A., Ulmert, David, Strand, Sven-Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531309/
https://www.ncbi.nlm.nih.gov/pubmed/31149033
http://dx.doi.org/10.7150/thno.31179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531309/
https://www.ncbi.nlm.nih.gov/pubmed/31149033
http://dx.doi.org/10.7150/thno.31179

Ejemplares similares